PATH | VRL
Menu

Elimination of Haemophilus influenzae type b (Hib) Disease From The Gambia After the Introduction of Routine Immunisation With a Hib Conjugate Vaccine: A Prospective Study

Routine immunization of infants in The Gambia with a Haemophilus influenzae type b (Hib) polysaccharide-tetanus toxoid conjugate vaccine began in May 1997. This article, published in The Lancet, reports on a study that investigated the effectiveness of the vaccine when delivered through the expanded program on immunization and the effect of national immunization on incidence of Hib disease. The authors found that the Gambian Hib immunization program reduced the occurrence of Hib disease despite irregular vaccine supply. They concluded that the effect of this program has important implications for the introduction of the vaccine into routine immunization programs of other developing countries.

Author: Adegbola RA, Secka O, Lahai G, et al.

Published: 2005

» Visit web page (English)

(Located at www.sciencedirect.com)

Citation: Adegbola RA, Secka O, Lahai G, et al. Elimination of Haemophilus influenzae type b (Hib) Disease From The Gambia After the Introduction of Routine Immunisation With a Hib Conjugate Vaccine: A Prospective Study. The Lancet. 2005;366(9480):144-150.

Resource types: Peer-reviewed journal

Diseases/vaccines: Haemophilus influenzae type b (Hib)

Topics: Introduction and service delivery, Disease burden and surveillance, Disease/vaccine specific information

Regions: Africa